Gemfibrozil treatment of hypertriglyceridemia: Improvement on fibrinolysis without change of insulin resistance

The fibrinolytic and metabolic changes associated with gemfibrozil treatment of hypertriglyceridemia were evaluated in 16 patients with type IV hyperlipidemia by criteria of triglyceride levels >250 mg/dl and total cholesterol levels

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 1997-09, Vol.134 (3), p.565-571
Hauptverfasser:	Jeng, Jing-Ren, Jeng, Chii-Yuan, Sheu, Wayne Huey-Herng, Lee, May Meei-Shyuan, Huang, Shyuh-Huei, Shieh, Shyh-Ming
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Biological and medical sciences Cholesterol, HDL - blood Female Fibrinolysis - drug effects Gemfibrozil - pharmacology Gemfibrozil - therapeutic use General and cellular metabolism. Vitamins Humans Hypertriglyceridemia - blood Hypertriglyceridemia - drug therapy Hypertriglyceridemia - physiopathology Hypolipidemic Agents - pharmacology Hypolipidemic Agents - therapeutic use Insulin Resistance Male Medical sciences Middle Aged Pharmacology. Drug treatments Triglycerides - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The fibrinolytic and metabolic changes associated with gemfibrozil treatment of hypertriglyceridemia were evaluated in 16 patients with type IV hyperlipidemia by criteria of triglyceride levels >250 mg/dl and total cholesterol levels
ISSN:	0002-8703 1097-6744
DOI:	10.1016/S0002-8703(97)70096-6